Interestingly, many studies [27,28] reported that the median plasma level of E2 is around 10 pg/mL (approximately equal to 30 pM) in post-menopausal ERα+ breast cancer patients, and intra-tumoral E2 levels are 10 to 20 times higher than those in plasma. The gene discussed is ESR1; the disease is breast cancer.